Systemic therapies for metastatic hormone-sensitive prostate cancer: network meta-analysis.

Keiichiro Mori Hadi Mostafai Reza Sari MotlaghBenjamin PradereFahad QuhalEkaterina LaukhtinaVictor M SchuettfortGero KramerMohammad AbufarajPierre I KarakiewiczTakahiro KimuraShin EgawaShahrokh F Shariat

Published in: BJU international (2021)

All three ARIs are effective therapies for mHSPC; apalutamide was the best tolerated. All three seemed more effective than docetaxel. These findings may facilitate individualised treatment strategies and inform future comparative trials.

Keyphrases

prostate cancer
systematic review
radical prostatectomy
squamous cell carcinoma
small cell lung cancer
meta analyses
current status
radiation therapy